Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.Medivir, a Sweden-based developer of pharmaceuticals against infectious diseases, has named Maris Hartmanis as new president and CEO.
Subscribe to our email newsletter
Hartmanis held leadership positions in Gambro, Amersham and Pharmacia and was appointed as CEO of the specialty pharmaceutical company BioPhausia in 2010.
Medivir chairman of the board Goran Pettersson said through the appointment of Maris Hartmanis as CEO, they secure an appropriate succession of the leadership of Medivir and a continued positive development of Medivir as a research-based specialty pharmaceutical company.